» Articles » PMID: 1900952

Split Anergy in a CD8+ T Cell: Receptor-dependent Cytolysis in the Absence of Interleukin-2 Production

Overview
Journal Science
Specialty Science
Date 1991 Mar 8
PMID 1900952
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Engagement of the antigen-specific receptor (TCR) of CD4+ T lymphocytes without a second (costimulatory) signal prevents the subsequent production of interleukin-2 (IL-2) by these cells. Because IL-2 is a key immunoregulatory lymphokine and is also produced by a subset of CD8+ T cells that are able to kill target cells, the effect of engaging the TCR of one such clone in the absence of costimulatory signals was examined. The capacity for TCR-dependent IL-2 production was lost, indicating comparable costimulator-dependent signaling requirements for IL-2 production in CD4+ and CD8+ T cells. However, TCR-mediated cytotoxicity was not impaired, implying that costimulation is required for only certain TCR-dependent effector functions.

Citing Articles

Hallmarks of CD8 T cell dysfunction are established within hours of tumor antigen encounter before cell division.

Rudloff M, Zumbo P, Favret N, Roetman J, Detres Roman C, Erwin M Nat Immunol. 2023; 24(9):1527-1539.

PMID: 37537361 PMC: 10878719. DOI: 10.1038/s41590-023-01578-y.


NK cells reduce anergic T cell development in early-stage tumors by promoting myeloid cell maturation.

Lindsay R, Melssen M, Stasiak K, Annis J, Woods A, Rodriguez A Front Oncol. 2022; 12:1058894.

PMID: 36531040 PMC: 9755581. DOI: 10.3389/fonc.2022.1058894.


The Great War of Today: Modifications of CAR-T Cells to Effectively Combat Malignancies.

Zhylko A, Winiarska M, Graczyk-Jarzynka A Cancers (Basel). 2020; 12(8).

PMID: 32722109 PMC: 7466082. DOI: 10.3390/cancers12082030.


Engineering CD4+ T Cells to Enhance Cancer Immunity.

Sillito F, Holler A, Stauss H Cells. 2020; 9(7).

PMID: 32708397 PMC: 7407306. DOI: 10.3390/cells9071721.


Chimeric antigen receptor signaling: Functional consequences and design implications.

Lindner S, Johnson S, Brown C, Wang L Sci Adv. 2020; 6(21):eaaz3223.

PMID: 32637585 PMC: 7314561. DOI: 10.1126/sciadv.aaz3223.